Acetylcholine-d13 bromide

• CAT Number: S001037
• Molecular Formula: C7H3D13BrNO2
• Molecular Weight: 239.19
• Purity: ≥95%
• Target: Metabolic Enzyme/Protease
• IUPAC Name: (2-acetyloxy-1,1,2,2-tetradeuterioethyl)-tris(trideuteriomethyl)azanium;bromide
• InChI: InChI=1S/C7H16NO2.BrH/c1-7(9)10-6-5-8(2,3)4;/h5-6H2,1-4H3;1H/q+1;/p-1/i2D3,3D3,4D3,5D2,6D2
• InChIKey: ZEHGKSPCAMLJDC-TZYVXOAQSA-M
• SMILES: [2H]C([2H])([2H])[N+](C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])C([2H])([2H])OC(=O)C.[Br-]

Acetylcholine-d13 Bromide is a high-purity deuterated compound essential for advanced pharmaceutical and biochemical research. This isotopically labeled version of Acetylcholine is crucial for studies involving neurotransmission, cholinergic signaling, and receptor binding assays. Featuring thirteen deuterium atoms, it ensures precise and reliable analytical results. Its advanced formulation provides enhanced stability and consistency, making it suitable for various experimental setups. Ideal for neuropharmacology research and drug development, Acetylcholine-d13 Bromide integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.